Fibroblast Growth Factor 23, Mineral Metabolism, and Adiposity in Normal Kidney Function

Up-regulation of FGF23 release by aldosterone

(2016) Bingbing Zhang et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Parathyroid hormone 1 receptor is essential to induce FGF23 production and maintain systemic mineral ion homeostasis

(2016) Yi Fan et al.   FASEB JOURNAL

Expression of Fgf23 in Activated Dendritic Cells and Macrophages in Response to Immunological Stimuli in Mice

(2015) Yuki Masuda et al.   BIOLOGICAL & PHARMACEUTICAL BULLETIN

FGF23 gene regulation by 1,25-dihydroxyvitamin D: opposing effects in adipocytes and osteocytes

(2015) Ichiro Kaneko et al.   JOURNAL OF ENDOCRINOLOGY

Impact of adiposity on cellular adhesion: The Multi-Ethnic Study of atherosclerosis (MESA)

(2015) Mary J. Christoph et al.   Obesity

Tissue-specific actions of the metabolic hormones FGF15/19 and FGF21

(2015) Bryn M. Owen et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

Elevated Fibroblast Growth Factor 23 Concentration: Prediction of Mortality among Chronic Kidney Disease Patients

(2015) Shahanas Chathoth et al.   CardioRenal Medicine

Fibroblast Growth Factor-23 and Cardiovascular Disease in the General Population

(2014) Bryan Kestenbaum et al.   Circulation-Heart Failure

Accuracy of GFR Estimation in Obese Patients

(2014) S. Lemoine et al.   Clinical Journal of the American Society of Nephrology

Increasing Adiposity Is Associated With Higher Adipokine Levels and Lower Bone Mineral Density in Obese Older Adults

(2014) Lina Aguirre et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Visceral Adiposity and the Risk of Metabolic Syndrome Across Body Mass Index

(2014) Ravi V. Shah et al.   JACC-Cardiovascular Imaging

Fat and Bone Interactions

(2014) Sandra Bermeo et al.   Current Osteoporosis Reports

Estimating mean annual 25-hydroxyvitamin D concentrations from single measurements: the Multi-Ethnic Study of Atherosclerosis

(2013) Michael C Sachs et al.   AMERICAN JOURNAL OF CLINICAL NUTRITION

A New Equation to Estimate Glomerular Filtration Rate

(2013) Andrew S. Levey et al.   ANNALS OF INTERNAL MEDICINE

Parathyroid hormone and arterial dysfunction in the multi-ethnic study of atherosclerosis

(2013) Cortney Bosworth et al.   CLINICAL ENDOCRINOLOGY

Influence of Estrogen Therapy on Calcium, Phosphorus, and Other Regulatory Hormones in Postmenopausal Women: The MESA Study

(2013) Nisha Bansal et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Abdominal Fat Is Associated With Lower Bone Formation and Inferior Bone Quality in Healthy Premenopausal Women: A Transiliac Bone Biopsy Study

(2013) Adi Cohen et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

The relationship between adipose tissue and bone metabolism

(2012) Jeffrey M. Gimble et al.   CLINICAL BIOCHEMISTRY

Fibroblast Growth Factor 21 as an emerging metabolic regulator: clinical perspectives

(2012) Y. C. Woo et al.   CLINICAL ENDOCRINOLOGY

Fibroblast Growth Factor-23 and Death, Heart Failure, and Cardiovascular Events in Community-Living Individuals

(2012) Joachim H. Ix et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Higher fibroblast growth factor-23 increases the risk of all-cause and cardiovascular mortality in the community

(2012) Johan Ärnlöv et al.   KIDNEY INTERNATIONAL

Applicability of fibroblast growth factor 23 for evaluation of risk of vertebral fracture and chronic kidney disease-mineral bone disease in elderly chronic kidney disease patients

(2012) Eiichiro Kanda et al.   BMC Nephrology

Obesity Is Not Protective against Fracture in Postmenopausal Women: GLOW

(2011) Juliet E. Compston et al.   AMERICAN JOURNAL OF MEDICINE

Parathyroid hormone receptor signaling in osteocytes increases the expression of fibroblast growth factor-23 in vitro and in vivo

(2011) Yumie Rhee et al.   BONE

Obesity and fracture in men and women: An epidemiologic perspective

(2011) Carrie M Nielson et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Effects of obesity on bone metabolism

(2011) Jay J Cao   Journal of Orthopaedic Surgery and Research

Circulating Fibroblast Growth Factor-23 Is Associated With Fat Mass and Dyslipidemia in Two Independent Cohorts of Elderly Individuals

(2010) Majd A.I. Mirza et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Is obesity protective for osteoporosis? Evaluation of bone mineral density in individuals with high body mass index

(2010) E. A. Greco et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Leptin stimulates fibroblast growth factor 23 expression in bone and suppresses renal 1α,25-dihydroxyvitamin D3 synthesis in leptin-deficient ob/ob Mice

(2010) Kiyomi Tsuji et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Serum fibroblast growth factor-23 (FGF-23) and fracture risk in elderly men

(2010) Majd AI Mirza et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Diagnosis and Classification of Diabetes Mellitus

(2009)   DIABETES CARE

Obesity and fractures in postmenopausal women

(2009) Melissa Orlandin Premaor et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Reciprocal Relations of Subcutaneous and Visceral Fat to Bone Structure and Strength

(2009) Vicente Gilsanz et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Bone as an endocrine organ

(2009) Seiji Fukumoto et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM